Oxetorone: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) Created page with "__NOTOC__" |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{XXXXX}} | |||
{{CMG}}; {{AE}} {{PB}} | |||
'''''For patient information about Oxetorone, click [[Oxetorone (patient information)|here]].''''' | |||
{{SB}} <sup>®</sup>, | |||
==Overview== | |||
{{Drugbox | |||
| verifiedrevid = 444750715 | |||
| IUPAC_name = (3''Z'')-3-[1]benzofuro[3,2-''c''][1]benzoxepin-6(12''H'')-ylidene-''N,N''-dimethylpropan-1-amine | |||
| image = Oxetorone.png | |||
| width = 180 | |||
| alt = Ball-and-stick model | |||
| image2 = Oxetorone-3D-balls.png | |||
| alt2 = Ball-and-stick model | |||
<!--Clinical data--> | |||
| tradename = | |||
| Drugs.com = {{drugs.com|international|oxetorone}} | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| pregnancy_US = <!-- A / B / C / D / X --> | |||
| pregnancy_category = | |||
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> | |||
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> | |||
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> | |||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | |||
| legal_status = | |||
| routes_of_administration = | |||
<!--Pharmacokinetic data--> | |||
| bioavailability = | |||
| protein_bound = | |||
| metabolism = | |||
| elimination_half-life = | |||
| excretion = | |||
<!--Identifiers--> | |||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 26020-55-3 | |||
| ATC_prefix = N02 | |||
| ATC_suffix = CX06 | |||
| PubChem = 6436540 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = T3XOS33TIQ | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D08312 | |||
<!--Chemical data--> | |||
| chemical_formula = | |||
| C=21 | H=21 | N=1 | O=2 | |||
| molecular_weight = 319.40 g/mol | |||
| smiles = CN(C)CCC=C1C2=CC=CC=C2OCC3=C1OC4=CC=CC=C34 | |||
}} | |||
'''Oxetorone''' is an [[antimigraine]] agent.<ref name="pmid11139754">{{cite journal |author=Massiou H |title=[Prophylactic treatments of migraine] |language=French |journal=Rev. Neurol. (Paris) |volume=156 Suppl 4 |issue= |pages=4S79–86 |year=2000 |pmid=11139754 |doi= |url=http://www.masson.fr/masson/79997}}</ref> | |||
Association with [[hyperprolactinemia]] has been described.<ref name="pmid8980859">{{cite journal |author=Pradalier A |title=Hyperprolactinaemia and depression induced by oxetorone |journal=Cephalalgia |volume=16 |issue=8 |pages=560–1 |date=December 1996 |pmid=8980859 |doi= 10.1046/j.1468-2982.1996.1608560.x|url=http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0333-1024&date=1996&volume=16&issue=8&spage=560}}</ref> | |||
<ref>{{Cite web | last = | first = | title = Oxetorone - Wikipedia, the free encyclopedia | url = http://en.wikipedia.org/wiki/Oxetorone | publisher = | date = | accessdate = }}</ref> Normal 0 false false false EN-US X-NONE X-NONE | |||
==References== | |||
{{Reflist|2}} | |||
[[Antimigraine preparations]] | |||
[[Category:Drugs]] |
Revision as of 18:39, 12 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information about Oxetorone, click here.
Synonyms / Brand Names: ®,
Overview
Ball-and-stick model | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C21H21NO2 |
Molar mass | 319.40 g/mol |
3D model (JSmol) | |
| |
(verify) |
Oxetorone is an antimigraine agent.[1]
Association with hyperprolactinemia has been described.[2]
[3] Normal 0 false false false EN-US X-NONE X-NONE
References
- ↑ Massiou H (2000). "[Prophylactic treatments of migraine]". Rev. Neurol. (Paris) (in French). 156 Suppl 4: 4S79–86. PMID 11139754.
- ↑ Pradalier A (December 1996). "Hyperprolactinaemia and depression induced by oxetorone". Cephalalgia. 16 (8): 560–1. doi:10.1046/j.1468-2982.1996.1608560.x. PMID 8980859.
- ↑ "Oxetorone - Wikipedia, the free encyclopedia".
Categories:
- Pages with script errors
- CS1 maint: Unrecognized language
- Pages with broken file links
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Drugs